Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study

Shuang Hao1, Andreas Karlsson1, Emelie Heintz2

  • 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Summary

Magnetic resonance imaging (MRI) combined with targeted biopsy (TBx) is a cost-effective strategy for early prostate cancer detection in Sweden. This approach significantly reduces biopsies compared to systematic biopsy (SBx) alone, with MRI + TBx being the optimal choice.